Survival in dementia and predictors of mortality: a review†
Corresponding Author
Stephen Todd
Care of the Elderly Medicine, Altnagelvin Hospital, Western Health and Social Care Trust, Londonderry, UK
Correspondence to: Stephen Todd, MD, E-mail: [email protected]Search for more papers by this authorStephen Barr
South West Acute Hospital, Western Health and Social Care Trust, Enniskillen, UK
Search for more papers by this authorMark Roberts
Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast, UK
Search for more papers by this authorA Peter Passmore
Centre for Public Health, School of Medicine Dentistry and Biomedical Sciences, The Queen's University of Belfast, Belfast, UK
Search for more papers by this authorCorresponding Author
Stephen Todd
Care of the Elderly Medicine, Altnagelvin Hospital, Western Health and Social Care Trust, Londonderry, UK
Correspondence to: Stephen Todd, MD, E-mail: [email protected]Search for more papers by this authorStephen Barr
South West Acute Hospital, Western Health and Social Care Trust, Enniskillen, UK
Search for more papers by this authorMark Roberts
Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast, UK
Search for more papers by this authorA Peter Passmore
Centre for Public Health, School of Medicine Dentistry and Biomedical Sciences, The Queen's University of Belfast, Belfast, UK
Search for more papers by this authorResearch conducted at: Centre for Public Health, School of Medicine Dentistry and Biomedical Sciences, The Queens University of Belfast, Belfast, BT7 9BL, UK.
Abstract
Objective
Dementia is an important cause of mortality and, with the ageing population and increasing prevalence of dementia, reliable data on prognosis and survival will be of interest to patients and caregivers as well as providers and commissioners of health and social care. A review of the literature was undertaken to determine the rates of survival in dementia and Alzheimer's disease (AD) and to identify factors that are or are not predictive of mortality in dementia and AD.
Methods
Relevant articles on mortality in dementia were identified following a search of several electronic databases from 1990 to September 2012. Inclusion criteria were reports on prospective community or clinic based cohorts published in English since 1990, to reflect more recent recognition of possible predictors.
Results
Median survival time from age of onset of dementia ranges from 3.3 to 11.7 years, with most studies in the 7 to 10-year period. Median survival time from age of disease diagnosis ranges from 3.2 to 6.6 years for dementia or AD cohorts as a whole. Age was consistently reported as a predictor of mortality, with male gender a less consistent predictor. Increased disease severity and functional impairment were often associated with mortality.
Conclusions
Substantial heterogeneity in the design of included studies limits the ability to prognosticate for individual patients. However, it is clear that dementia and AD are associated with significant mortality. Reasons for the increased mortality are not established. Copyright © 2013 John Wiley & Sons, Ltd.
References
- Aevarsson O, Svanborg A, Skoog I. 1998. Seven-year survival rate after age 85 years: relation to Alzheimer disease and vascular dementia. Arch Neurol 55: 1226–1232.
- Aguero-Torres H, Fratiglioni L, Guo Z, Viitanen M, Winblad B. 1998. Prognostic factors in very old demented adults: a seven-year follow-up from a population-based survey in Stockholm. J Am Geriatr Soc 46: 444–452.
- Aguero-Torres H, Fratiglioni L, Guo Z, Viitanen M, Winblad B. 1999. Mortality from dementia in advanced age: a 5-year follow-up study of incident dementia cases. J Clin Epidemiol 52: 737–743.
- Andersen K, Lolk A, Martinussen T, Kragh-Sorensen P. 2010. Very mild to severe dementia and mortality: a 14-year follow-up – The Odense study. Dement Geriatr Cogn Disord 29: 61–67. DOI: 10.1159/000265553
- Aronson MK, Ooi WL, Geva DL, et al. 1991. Dementia. Age-dependent incidence, prevalence, and mortality in the old. Arch Intern Med 151: 989–992.
- Baldereschi M, Di Carlo A, Maggi S, et al. 1999. Dementia is a major predictor of death among the Italian elderly. ILSA Working Group. Italian Longitudinal Study on Aging. Neurology 52: 709–713.
- Barclay LL, Zemcov A, Blass JP, Sansone J. 1985. Survival in Alzheimer's disease and vascular dementias. Neurology 35: 834–840.
- Barnes DE, Yaffe K. 2011. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol 10: 819–828. DOI: 10.1016/S1474-4422(11)70072-2
- Blessed G, Tomlinson BE, Roth M. 1968. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 114: 797–811.
- Borjesson-Hanson A, Gustafson D, Skoog I. 2007. Five-year mortality in relation to dementia and cognitive function in 95-year-olds. Neurology 69: 2069–2075. DOI: 10.1212/01.wnl.0000280464.59322.af
- Brookmeyer R, Corrada MM, Curriero FC, Kawas C. 2002. Survival following a diagnosis of Alzheimer disease. Arch Neurol 59: 1764–1767.
- Claus JJ, van Gool WA, et al. 1998. Predicting survival in patients with early Alzheimer's disease. Dement Geriatr Cogn Disord 9: 284–293.
- Claus JJ, Walstra GJ, Bossuyt PM, Teunisse S, Van Gool WA. 1999. A simple test of copying ability and sex define survival in patients with early Alzheimer's disease. Psychol Med. 29(2): 485–489.
- Daviglus ML, Plassman BL, Pirzada A, et al. 2011. Risk factors and preventive interventions for Alzheimer disease: state of the science. Arch Neurol 68: 1185–1190. DOI: 10.1001/archneurol.2011.100
- EClipSE Collaborative Members, Brayne C, Ince PG, et al. 2010. Education, the brain and dementia: neuroprotection or compensation? Brain 133: 2210–2216. DOI: 10.1093/brain/awq185
- Folstein MF, Folstein SE, McHugh PR. 1975. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189–198.
- Freels S, Nyenhuis DL, Gorelick PB. 2002. Predictors of survival in African American patients with AD, VaD, or stroke without dementia. Neurology 59: 1146–1153.
- Ganguli M, Dodge HH, Shen C, Pandav RS, DeKosky ST. 2005. Alzheimer disease and mortality: a 15-year epidemiological study. Arch Neurol 62: 779–784. DOI: 10.1001/archneur.62.5.779
- Guehne U, Riedel-Heller S, Angermeyer MC. 2005. Mortality in dementia. Neuroepidemiology 25: 153–162. DOI: 10.1159/000086680
- Guhne U, Matschinger H, Angermeyer MC, Riedel-Heller SG. 2006. Incident dementia cases and mortality. Results of the Leipzig Longitudinal Study of the Aged (LEILA75+). Dement Geriatr Cogn Disord 22: 185–193. DOI: 10.1159/000094786
- Habbema JD, Dippel DW. 1986. Survivors-only bias in estimating survival in Alzheimer's disease and vascular dementias. Neurology 36: 1009–1010.
- Heeren TJ, van Hemert AM, Rooymans HG. 1992. A community-based study of survival in dementia. Acta Psychiatr Scand 85: 415–418.
- Helmer C, Joly P, Letenneur L, Commenges D, Dartigues JF. 2001. Mortality with dementia: results from a French prospective community-based cohort. Am J Epidemiol 154: 642–648.
- Helzner EP, Scarmeas N, Cosentino S, et al. 2008. Survival in Alzheimer disease: a multiethnic, population-based study of incident cases. Neurology 71: 1489–1495. DOI: 10.1212/01.wnl.0000334278.11022.42
- Heyman A, Peterson B, Fillenbaum G, Pieper C. 1996. The consortium to establish a registry for Alzheimer's disease (CERAD). Part XIV: demographic and clinical predictors of survival in patients with Alzheimer's disease. Neurology 46: 656–660.
- Hier DB, Warach JD, Gorelick PB, Thomas J. 1989. Predictors of survival in clinically diagnosed Alzheimer's disease and multi-infarct dementia. Arch Neurol 46: 1213–1216.
- Hogan DB, Thierer DE, Ebly EM, Parhad IM. 1994. Progression and outcome of patients in a Canadian dementia clinic. Can J Neurol Sci 21: 331–338.
- Jagger C, Clarke M, Stone A. 1995. Predictors of survival with Alzheimer's disease: a community-based study. Psychol Med 25: 171–177.
- Jost BC, Grossberg GT. 1995. The natural history of Alzheimer's disease: a brain bank study. J Am Geriatr Soc 43: 1248–1255.
- Keene J, Hope T, Fairburn CG, Jacoby R. 2001. Death and dementia. Int J Geriatr Psychiatry 16: 969–974.
- Koutsavlis AT, Wolfson C. 2000. Elements of mobility as predictors of survival in elderly patients with dementia: findings from the Canadian Study of Health and Aging. Chronic Dis Can 21: 93–103.
- Larson EB, Shadlen MF, Wang L, et al. 2004. Survival after initial diagnosis of Alzheimer disease. Ann Intern Med 140: 501–509.
- Launer LJ, Hughes T, Yu B, et al. 2010. Lowering midlife levels of systolic blood pressure as a public health strategy to reduce late-life dementia: perspective from the Honolulu Heart Program/Honolulu Asia Aging Study. Hypertension 55: 1352–1359. DOI: 10.1161/HYPERTENSIONAHA.109.147389
- Letenneur L, Launer LJ, Andersen K, et al. 2000. Education and the risk for Alzheimer's disease: sex makes a difference. EURODEM pooled analyses. EURODEM Incidence Research Group. Am J Epidemiol 151: 1064–1071.
- Little DM, Crooks VC, Petitti DB, et al. 2009. Mortality, dementia, and apolipoprotein E genotype in elderly white women in the United States. J Am Geriatr Soc 57: 231–236. DOI: 10.1111/j.1532-5415.2008.02113.x
- Llinas-Regla J, Lopez-Pousa S, Vilalta-Franch J, Garre-Olmo J, Roman GC. 2008. Mortality after a diagnosis of dementia in a population aged 75 and over in Spain. Neuroepidemiology 31: 80–88. DOI: 10.1159/000144088
- Luengo-Fernadez R, Leal J, Gray A. 2010. Dementia 2010. The economic burden of dementia and associated research funding in the UK.
- Mahoney FI, Barthel DW. 1965. Functional evaluation: the Barthel index. Md State Med J 14: 61–65.
- McGuinness B, Craig D, Bullock R, Passmore P. 2009a. Statins for the prevention of dementia. Cochrane Database Syst Rev (2): CD003160. DOI: 10.1002/14651858.CD003160.pub2
- McGuinness B, Todd S, Passmore P, Bullock R. 2009b. Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database Syst Rev (4): CD004034. DOI: 10.1002/14651858.CD004034.pub3
- Mehta KM, Yaffe K, Perez-Stable EJ, et al. 2008. Race/ethnic differences in AD survival in US Alzheimer's disease centers. Neurology 70: 1163–1170. DOI: 10.1212/01.wnl.0000285287.99923.3c
- Molsa PK, Marttila RJ, Rinne UK. 1986. Survival and cause of death in Alzheimer's disease and multi-infarct dementia. Acta Neurol Scand 74: 103–107.
- Molsa PK, Marttila RJ, Rinne UK. 1995. Long-term survival and predictors of mortality in Alzheimer's disease and multi-infarct dementia. Acta Neurol Scand 91: 159–164.
- Morris JC. 1993. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43: 2412–2414.
- National Audit Office. 2007. Improving services and support for people with dementia. Report by the Comptroller and Auditor General.
- National Collaborating Centre for Mental Health. 2007. Dementia: a NICE-SCIE guideline on supporting people with dementia and their carers in health and social care.
- Nitrini R, Caramelli P, Herrera E, Jr, et al. 2005. Mortality from dementia in a community-dwelling Brazilian population. Int J Geriatr Psychiatry 20: 247–253. DOI: 10.1002/gps.1274
- Noale M, Maggi S, Minicuci N, et al. 2003. Dementia and disability: impact on mortality. The Italian Longitudinal Study on Aging. Dement Geriatr Cogn Disord 16: 7–14. DOI: 10.1159/000069987
- Paradise M, Cooper C, Livingston G. 2009. Systematic review of the effect of education on survival in Alzheimer's disease. Int Psychogeriatr 21: 25–32. DOI: 10.1017/S1041610208008053
- Pasquier F, Richard F, Lebert F. 2004. Natural history of frontotemporal dementia: comparison with Alzheimer's disease. Dement Geriatr Cogn Disord 17: 253–257. DOI: 10.1159/000077148
- Qiu C, Winblad B, Fratiglioni L. 2005. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 4: 487–499. DOI: 10.1016/S1474-4422(05)70141-1
- Rait G, Walters K, Bottomley C, et al. 2010. Survival of people with clinical diagnosis of dementia in primary care: cohort study. BMJ 341: c3584. DOI: 10.1136/bmj.c3584
- Rascovsky K, Salmon DP, Lipton AM, et al. 2005. Rate of progression differs in frontotemporal dementia and Alzheimer disease. Neurology 65: 397–403. DOI: 10.1212/01.wnl.0000171343.43314.6e
- Richard E, Kuiper R, Dijkgraaf MG, Van Gool WA, Evaluation of vascular care in Alzheimer's disease. 2009. Vascular care in patients with Alzheimer's disease with cerebrovascular lesions-a randomized clinical trial. J Am Geriatr Soc 57: 797–805.
- Roberson ED, Hesse JH, Rose KD, et al. 2005. Frontotemporal dementia progresses to death faster than Alzheimer disease. Neurology 65: 719–725. DOI: 10.1212/01.wnl.0000173837.82820.9f
- Roth M, Tym E, Mountjoy CQ, et al. 1986. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 149: 698–709.
- Scarmeas N, Luchsinger JA, Mayeux R, Stern Y. 2007. Mediterranean diet and Alzheimer disease mortality. Neurology 69: 1084–1093. DOI: 10.1212/01.wnl.0000277320.50685.7c
- Schaufele M, Bickel H, Weyerer S. 1999. Predictors of mortality among demented elderly in primary care. Int J Geriatr Psychiatry 14: 946–956.
10.1002/(SICI)1099-1166(199911)14:11<946::AID-GPS45>3.0.CO;2-9 CASPubMedWeb of Science®Google Scholar
- Schoenberg BS, Kokmen E, Okazaki H. 1987. Alzheimer's disease and other dementing illnesses in a defined United States population: incidence rates and clinical features. Ann Neurol 22: 724–729. DOI: 10.1002/ana.410220608
- Sparks DL, Sabbagh MN, Breitner JC, et al. 2003. Is cholesterol a culprit in Alzheimer's disease? Int Psychogeriatr 15 Suppl 1: 153–159. DOI: 10.1017/S1041610203009128
- Stern Y, Brandt J, Albert M, et al. 1997a. The absence of an apolipoprotein epsilon4 allele is associated with a more aggressive form of Alzheimer's disease. Ann Neurol 41: 615–620. DOI: 10.1002/ana.410410510
- Stern Y, Tang MX, Albert MS, et al. 1997b. Predicting time to nursing home care and death in individuals with Alzheimer disease. JAMA 277: 806–812.
- Storandt M, Grant EA, Miller JP, Morris JC. 2002. Rates of progression in mild cognitive impairment and early Alzheimer's disease. Neurology 59: 1034–1041.
- Tschanz JT, Corcoran C, Skoog I, et al. 2004. Dementia: the leading predictor of death in a defined elderly population: the Cache County Study. Neurology 62: 1156–1162.
- Valenzuela M, Brayne C, Sachdev P, Wilcock G, Matthews F, Medical Research Council Cognitive Function and Ageing Study. 2011. Cognitive lifestyle and long-term risk of dementia and survival after diagnosis in a multicenter population-based cohort. Am J Epidemiol 173: 1004–1012. DOI: 10.1093/aje/kwq476
- van Dijk PT, Dippel DW, Habbema JD. 1991. Survival of patients with dementia. J Am Geriatr Soc 39: 603–610.
- Walsh JS, Welch HG, Larson EB. 1990. Survival of outpatients with Alzheimer-type dementia. Ann Intern Med 113: 429–434.
- Waring SC, Doody RS, Pavlik VN, Massman PJ, Chan W. 2005. Survival among patients with dementia from a large multi-ethnic population. Alzheimer Dis Assoc Disord 19: 178–183.
- Weiner MF, Rosenberg RN, Svetlik D, et al. 2003. Comparison of Alzheimer's disease in Native Americans and Whites. Int Psychogeriatr 15: 367–375.
- Williams MM, Xiong C, Morris JC, Galvin JE. 2006. Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease. Neurology 67: 1935–1941. DOI: 10.1212/01.wnl.0000247041.63081.98
- Wilson RS. 2008. Advancing age, impending death, and declining cognition. Neurology 71: 874–875. DOI: 10.1212/01.wnl.0000325993.99091.3f
- Wilson RS, Aggarwal NT, Barnes LL, et al. 2009. Biracial population study of mortality in mild cognitive impairment and Alzheimer disease. Arch Neurol 66: 767–772. DOI: 10.1001/archneurol.2009.80
- Wolfson C, Wolfson DB, Asgharian M, et al. 2001. A reevaluation of the duration of survival after the onset of dementia. N Engl J Med 344: 1111–1116. DOI: 10.1056/NEJM200104123441501
- Xie J, Brayne C, Matthews FE, Medical Research Council Cognitive Function and Ageing Study collaborators. 2008. Survival times in people with dementia: analysis from population based cohort study with 14 year follow-up. BMJ 336: 258–262. DOI: 10.1136/bmj.39433.616678.25